
COVID-19: employment measures implemented in biotechnology companies in Spain 2020
More than 70% percent of the biotechnology companies surveyed by the Spanish Bioindustry Association (ASEBIO) stated that adjustments in the workdays and work schedule was the main employment measure implemented due to COVID-19. Furthermore, almost 10 percent of the respondents answered that a Record of Temporary Employment Regulation (ERTE) was the main employment measure taken by the company.